Latest filing published 21 Nov 2017 for Tivity Health, INC., €1.4M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Conan Laughlin: trading record in brief
Conan Laughlin discloses dealings in Tivity Health, Inc. to SEC (Form 4). In total, 48 filings cover trades dated from 19 May 2015 to 21 November 2017.
Both buying and selling appear: 20 purchases worth €7.2M, against 23 sales worth €133.1M. On balance, insiders were net sellers of €125.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. In 2017 alone, the filings show no purchases and 23 sales.
A typical purchase (the median) is worth €109k.
The newest entry dates from 21 November 2017: an open-market sale of €1.4M, in Tivity Health, Inc. The last insider purchase was made public on 17 November 2015, 4,009 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Conan Laughlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 48,000 shares@ US$34.811.0% of flowCommon StockSEC:0001140361-17-043615:0
- 21,330 shares@ US$34.810.4% of flowCommon StockSEC:0001140361-17-043615:1
- 10,670 shares@ US$34.810.2% of flowCommon StockSEC:0001140361-17-043615:2
- 36,000 shares@ US$35.010.7% of flowCommon StockSEC:0001140361-17-043615:3
- 16,000 shares@ US$35.010.3% of flowCommon StockSEC:0001140361-17-043615:4
- 8,000 shares@ US$35.010.2% of flowCommon StockSEC:0001140361-17-043615:5
- 69,050 shares@ US$33.871.3% of flowCommon StockSEC:0001140361-17-043249:0
- 30,690 shares@ US$33.870.6% of flowCommon StockSEC:0001140361-17-043249:1
- 15,347 shares@ US$33.870.3% of flowCommon StockSEC:0001140361-17-043249:2
- 137,400 shares@ US$34.402.7% of flowCommon StockSEC:0001140361-17-043249:3
- 61,070 shares@ US$34.401.2% of flowCommon StockSEC:0001140361-17-043249:4
- 30,530 shares@ US$34.400.6% of flowCommon StockSEC:0001140361-17-043249:5
- 87,550 shares@ US$34.611.7% of flowCommon StockSEC:0001140361-17-043249:6
- 38,910 shares@ US$34.610.8% of flowCommon StockSEC:0001140361-17-043249:7
- 19,453 shares@ US$34.610.4% of flowCommon StockSEC:0001140361-17-043249:8
- 72,000 shares@ US$47.522.0% of flowCommon StockSEC:0001140361-17-041575:0
- 32,000 shares@ US$47.520.9% of flowCommon StockSEC:0001140361-17-041575:1
- 16,000 shares@ US$47.520.4% of flowCommon StockSEC:0001140361-17-041575:2
- 1,300,000 shares@ US$37.9028.4% of flowCommon StockSEC:0001140361-17-030014:0
- 300,000 shares@ US$37.906.5% of flowCommon StockSEC:0001140361-17-030014:1
- 150,000 shares@ US$37.903.3% of flowCommon StockSEC:0001140361-17-030014:2
- 3,012 shares0Common StockSEC:0001140361-17-022648:0
- 1,750,000 shares@ US$28.3031.9% of flowCommon Stock, $0.001 Par ValueSEC:0000921895-17-000524:0
- 250,000 shares@ US$28.304.6% of flowCommon Stock, $0.001 Par ValueSEC:0000921895-17-000524:1
- 625,000 shares@ US$25.019.5% of flowCommon StockSEC:0001140361-16-078736:0
25 of 47 declarations